Page last updated: 2024-11-02

pindolol and Cyanosis

pindolol has been researched along with Cyanosis in 1 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kozlik, R1
Kramer, HH1
Wicht, H1
Krian, A1
Ostermeyer, J1
Reinhardt, D1

Other Studies

1 other study available for pindolol and Cyanosis

ArticleYear
Myocardial beta-adrenoceptor density and the distribution of beta 1- and beta 2-adrenoceptor subpopulations in children with congenital heart disease.
    European journal of pediatrics, 1991, Volume: 150, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Cyanosis; Down-Regulation; Epinephrine; Heart Defects, Congenit

1991